Perpetual LTD Amgen Inc Transaction History

Perpetual LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$262.75 - $319.31 $217,031 - $263,750	826 Added 18.97%	5,180 $1.62 Billion
Q1 2024 Apr 09, 2024	SELL	$268.87 - $324.56 $248,704 - $300,218	-925 Reduced 17.52%	4,354 $1.2 Billion
Q4 2023 Feb 15, 2024	BUY	$255.7 - $288.46 $37,332 - $42,115	146 Added 2.84%	5,279 $1.52 Billion
Q3 2023 Oct 10, 2023	BUY	$218.65 - $271.46 $410,843 - $510,073	1,879 Added 57.74%	5,133 $1.38 Billion
Q1 2023 May 08, 2023	SELL	$225.79 - $275.2 $519,317 - $632,960	-2,300 Reduced 41.41%	3,254 $787 Million
Q2 2020 Nov 18, 2020	BUY	$197.81 - $242.74 $1.1 Million - $1.35 Million	5,554 New	5,554 $2.76 Million
Q1 2020 Nov 18, 2020	SELL	$182.24 - $241.7 $1.01 Million - $1.34 Million	-5,554 Closed	0 $0
Q3 2019 Oct 10, 2019	SELL	$174.11 - $208.62 $139,288 - $166,896	-800 Reduced 12.59%	5,554 $1.08 Million
Q2 2019 Jul 30, 2019	SELL	$166.7 - $195.41 $83,350 - $97,705	-500 Reduced 7.3%	6,354 $1.17 Million
Q3 2018 Oct 30, 2018	SELL	$185.29 - $208.89 $314,993 - $355,113	-1,700 Reduced 19.87%	6,854 $1.42 Million
Q2 2018 Jul 23, 2018	BUY	$166.05 - $186.51 $1.42 Million - $1.6 Million	8,554 New	8,554 $1.58 Million

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Perpetual LTD, based on Form 13F filings with the SEC.

Stay updated on Perpetual LTD with notifications on news.